British regulators insist that “no corners have been cut” during the assessment of the COVID-19 vaccine developed by American drugmaker Pfizer and Germany’s BioNTech, which was cleared for emergency use on Wednesday.
In a briefing after the UK’s Medicines and Healthcare Products Regulatory Agency became the first regulator worldwide to approve the vaccine, its chair, Dr. June Raine, says the public can be “absolutely confident” that its standards are equivalent to those anywhere around the world.
Regulators also reveal the order by which the vaccine will be rolled out across the country over the coming weeks and months, beginning next week. The UK has ordered around 40 million doses of the vaccine, which can potentially immunize 20 million people as two doses are required.
Residents in nursing homes and their carers will be offered the vaccine first followed by those aged 80 and over and frontline health and social care workers. From there, the priority plan largely follows age groups.
According to Munir Pirmohamed, chair of a medicines panel, people will be immune seven days after the second dose.
— AP
It's not (only) about you.
Supporting The Times of Israel isn’t a transaction for an online service, like subscribing to Netflix. The ToI Community is for people like you who care about a common good: ensuring that balanced, responsible coverage of Israel continues to be available to millions across the world, for free.
Sure, we'll remove all ads from your page and you'll unlock access to some excellent Community-only content. But your support gives you something more profound than that: the pride of joining something that really matters.
Join the Times of Israel Community
Join our Community
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this